Transparency Market Research discusses the vital factors responsible for the ups and downs for players associated with animal health biotechnology. “Animal Health Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024” is an in-depth analysis of what trends currently influence both consumers and market players, in order to derive a feasible conclusion for the market’s future.
The primary factor attributed to the growth of the global animal health biotechnology market is the recent developments that have occurred in the fields of animal cloning and the progress in transgenic animals. Additionally, the animal health biotechnology benefits from an increasing rate of investments and project approvals by government bodies across the world. This is leading to a much faster rate of development in the global animal health biotechnology market, especially among the key players.
The creation of transgenic animals and the relative success in the process of cloning are expected to impart more resilience to livestock, making them more resistant to diseases. This will consequently benefit humanity as well as the environment. It is expected that the demand for these animals as livestock will improve significantly over the coming years, as the process becomes more and more successful. Government bodies are also taking notice of the advancements in the global animal health biotechnology market and allowing a greater scope of funding for newer projects.
Current developments in the global animal health biotechnology market include the development of several reagents and diagnostic techniques that are highly sensitive, easily reproducible, and fast action. A lot of these reagents have also been strengthened over time due to advancements in the molecular biology, immunology, and biochemistry. The global animal health biotechnology market has led to the development of new vaccines, including the new types of anti-idiotype, recombinant, synthetic, and subunit vaccines. Each type holds a high priority in stability, multi-valence, ease of use, the duration of protection, innocuity, and efficacy.
North America and Europe have consistently been the leading regional segments in the global animal health biotechnology market over the past few years. Key factors that have allowed the two regions to continue holding high market value include a high level of awareness among the population regarding cloning and transgenic products. Players based in these regions also receive a higher rate of investment by government and private entities, allowing them to make use of advanced technologies for research and development. Over time, Asia Pacific is expected to gain a serious share in the global animal health biotechnology market owing to the massive availability and dependence on livestock for food, transportation, and utility.
The leading players in the global animal health biotechnology market today, include Bayer AG, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Santa Cruz Biotechnology, Inc.